Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

I-Mab to Start US Phase I Trial of Immunotherapy for Alzheimer's

publication date: Jul 30, 2021

Shanghai's I-Mab has been cleared to start a US Phase I trial of its novel immunotherapy for Alzheimer's. Protollin is composed of outer membrane bacteria proteins complexed with lipopolysaccharides that is delivered nasally to cross the brain-blood barrier. It is aimed at stimulating an immune response against the build-up of beta amyloid protein plaques and subsequent tau tangles. I-Mab will develop protollin ex-China; Nhwa owns China rights. The two China biopharmas in-licensed global rights to the candidate from Boston's Brigham and Women's Hospital and Inspirevax, a Montreal biotech. More details....

Stock Symbol: (NSDQ: IMAB)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021